Form 15-12G CROSS COUNTRY HEALTHCARE
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 0-33169
Cross Country Healthcare, Inc.
(Exact name of registrant as specified in its charter)
5201 Congress Avenue, Suite 160
Boca Raton, FL 33487
Tel: (561) 998-2232
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common Stock, par value $0.0001 per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) | ☒ | |
| Rule 12g-4(a)(2) | ☐ | |
| Rule 12h-3(b)(1)(i) | ☒ | |
| Rule 12h-3(b)(1)(ii) | ☐ | |
| Rule 15d-6 | ☐ | |
| Rule 15d-22(b) | ☐ |
Approximate number of holders of record as of the certification or notice date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934, Cross Country Healthcare, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: July 27, 2026
| Cross Country Healthcare, Inc. | |||
| By: | /s/ Susan Ball | ||
| Name: | Susan Ball | ||
| Title: | General Counsel | ||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Traveler Spends 10+ Hours Researching Lake Como Hotels – Only 9 Make the Final Shortlist
- HelloNation Examines Bundling Insurance With Insights From Insurance Expert Jamie Smith
- Bladex announces Net Profit of $66.5 Million for the Second Quarter 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share